Since its creation, Truffle Capital has supported innovative companies which act as drivers of job creation and economic development. We continually build upon a unique portfolio of companies by proactively seeking investment opportunities, promoting spin-offs (from industrial groups, universities or laboratories) and aiding in the creation of new companies. This approach allows Truffle Capital to invest early in the life of a business at a low valuation providing investors the opportunity to benefit from future growth.
With an entrepreneurial approach to investment, Truffle Capital provides not only financial backing to its companies but also strategic assistance with a double purpose: transforming companies into leaders in their sector and generating higher potential returns for investors.
We often acquire large or majority holdings in companies to demonstrate our confidence in their projects and to best represent our investors’ interests. Truffle Capital helps companies:
Many factors have allowed a highly favorable environment for investments in the Life Sciences sector, factors such as the ageing population, a better understanding of the mechanisms of disease following the “biotechnological revolution”, a cost management policy in the health field, the need for pharmaceutical and medical equipment manufacturers to renew their product catalogues., We focus on three areas: vaccines and therapeutic drugs, medical devices and green chemistry.
Digital technologies are revolutionising current industries and are deeply transforming our modes of consumption, communication and interaction.
Truffle Capital has a strong focus on FinTech/InsurTech, and invest in technologies that will profoundly disrupt sectors such as: Big Data, Mobile & Cloud, Payments, Blockchain, Crowdlending, Digital Marketing, Internet of Things, and Cybersecurity.
Truffle Capital has financed several companies in the cleantech field. We continue to support these promising companies and assist them in their growth.
Connexion espace partenaire